Your session is about to expire
← Back to Search
Behavioral Intervention
Provider Education Model (PEM) for Autism Spectrum Disorder
N/A
Waitlist Available
Led By Rebecca Landa, PhD, CCC-SLP
Research Sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 months into treatment
Awards & highlights
Study Summary
This study is evaluating whether a training program can improve the use of evidence-based practices by early intervention providers.
Eligible Conditions
- Autism Spectrum Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 6 months into treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 months into treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Provider Delivery Service Practices
Secondary outcome measures
Change in Baseline Autism Diagnostic Observation Schedule
Change in Baseline Mullen Scales of Early Learning
Change in Caregiver Interaction with Child
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Provider Education Model (PEM)Experimental Treatment1 Intervention
condition wherein providers will receive specially structured training during their typical home visits based by Kennedy Krieger Institute (KKI) staff
Group II: Treatment-as-Usual (TAU)Active Control1 Intervention
condition wherein providers continue with their existing practices
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Provider Education Model (PEM)
2014
N/A
~80
Find a Location
Who is running the clinical trial?
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Lead Sponsor
88 Previous Clinical Trials
24,858 Total Patients Enrolled
15 Trials studying Autism Spectrum Disorder
3,399 Patients Enrolled for Autism Spectrum Disorder
Health Resources and Services Administration (HRSA)FED
84 Previous Clinical Trials
151,407 Total Patients Enrolled
11 Trials studying Autism Spectrum Disorder
2,168 Patients Enrolled for Autism Spectrum Disorder
Rebecca Landa, PhD, CCC-SLPPrincipal InvestigatorHugo W. Moser Research Institute at Kennedy Krieger, Inc.
7 Previous Clinical Trials
1,123 Total Patients Enrolled
7 Trials studying Autism Spectrum Disorder
1,123 Patients Enrolled for Autism Spectrum Disorder
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger